We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$2.41M
NCM
2
Nantahala Capital Management
Connecticut
$2.07M +$647K +36,021 +24%
SCM
3
Suvretta Capital Management
New York
$1.83M
RSCM
4
Rock Springs Capital Management
Maryland
$1.54M
BBA
5
Baker Bros. Advisors
New York
$1.53M
Millennium Management
6
Millennium Management
New York
$1.41M +$1.67M +92,672 +284%
SCM
7
Sio Capital Management
New York
$1.35M -$1.2M -66,543 -36%
Vanguard Group
8
Vanguard Group
Pennsylvania
$899K +$79.2K +4,408 +6%
O
9
OrbiMed
New York
$809K
ACM
10
Aisling Capital Management
New York
$761K
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$675K
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$625K +$663K +36,913 +197%
PVI
13
Pura Vida Investments
New York
$472K +$754K +41,948 New
SB
14
Samsara BioCapital
California
$398K
GTC
15
Ghost Tree Capital
New York
$360K -$144K -8,000 -20%
BlackRock
16
BlackRock
New York
$291K -$278K -15,469 -37%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$270K +$148K +8,257 +52%
SFM
18
Sphera Funds Management
Israel
$198K +$317K +17,633 New
Two Sigma Investments
19
Two Sigma Investments
New York
$177K +$209K +11,602 +280%
Assenagon Asset Management
20
Assenagon Asset Management
Luxembourg
$143K
Two Sigma Advisers
21
Two Sigma Advisers
New York
$123K -$98.6K -5,484 -33%
UOTTAIMCU
22
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$111K
A
23
Abingworth
United Kingdom
$108K
State Street
24
State Street
Massachusetts
$96.7K +$40.3K +2,240 +35%
Renaissance Technologies
25
Renaissance Technologies
New York
$68K -$71K -3,948 -40%